2009International Archives of Allergy and Applied ImmunologyRequires access

Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis

Anne Lassus

Open publisher page 20 citations

Abstract

Research Articles| July 23 2009 Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis Subject Area: Immunology and Allergy A. Lassus A. Lassus Department of Dermato-Venereology, University Central Hospital, Helsinki Search for other works by this author on: This Site PubMed Google Scholar International Archives of Allergy and Applied Immunology (1969) 36 (6): 515–522. https://doi.org/10.1159/000230771 Article history Received: February 12 1969 Published Online: July 23 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation A. Lassus; Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis. International Archives of Allergy and Applied Immunology 1 June 1969; 36 (6): 515–522. https://doi.org/10.1159/000230771 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Applied Immunology Search Advanced Search This content is only available via PDF. 1969Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.

About this research paper

What this paper is about

Research Articles| July 23 2009 Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis Subject Area: Immunology and Allergy A. Lassus A. Lassus Department of Dermato-Venereology, University Central Hospital, Helsinki Search for other works by this author on: This Site PubMed Google Scholar International Archives of Allergy and Applied Immunology (1969) 36 (6): 515–522. https://doi.org/10.1159/000230771 Article history Received: February 12 1969 Published Online: July 23 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation A. Lassus; Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis. International Archives of Allergy and Applied Immunology 1 June 1969; 36 (6): 515–522. https://doi.org/10.1159/000230771 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Applied Immunology Search Advanced Search This content is only available via PDF. 1969Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Research Articles| July 23 2009 Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis Subject Area: Immunology and Allergy A. Lassus A. Lassus Department of Dermato-Venereology, University Central Hospital, Helsinki Search for other works by this author on: This Site PubMed Google Scholar International Archives of Allergy and Applied Immunology (1969) 36 (6): 515–522. https://doi.org/10.1159/000230771 Article history Received: February 12 1969 Published Online: July 23 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation A. Lassus; Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis. International Archives of Allergy and Applied Immunology 1 June 1969; 36 (6): 515–522. https://doi.org/10.1159/000230771 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Applied Immunology Search Advanced Search This content is only available via PDF. 1969Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.

Key concepts: Icon, Citation, Medicine, Subject (documents), World Wide Web, Computer science, Library science, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Development of Rheumatoid Factor Activity and Cryoglobulins in Primary and Secondary Syphilis — Research Paper | ScholarLens